Sotera Health Company (SHC)
Stock Price:
$27.97 USD
1.21 (4.52%)
Updated November 27, 1:00 PM EST - Market closed
After-hours: $28.02 +0.05 (0.18%) Nov 27, 2:29 PM
Key Info
| Market Cap |
6.50B |
| Revenue (ttm) |
790.09M |
| Net Income (ttm) |
-28.48M |
| Shares Out |
279.00M |
| EPS (ttm) |
-0.10 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
November 27 |
| Last Price |
$27.97 |
| Previous Close |
$26.76 |
| Change ($) |
1.21 |
| Change (%) |
4.52% |
| Day's Open |
26.74 |
| Day's Range |
26.72 - 28.65 |
| Day's Volume |
3,429,301 |
| 52-Week Range |
24.05 - 29.00 |
More Stats
| Market Cap |
6.50B |
| Enterprise Value |
9.38B |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
279.00M |
| Float |
58.52M |
| EPS (basic) |
n/a |
| EPS (diluted) |
-0.10 |
| FCF / Share |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
8.23 |
| PB Ratio |
n/a |
| Revenue |
790.09M |
| Operating Income |
n/a |
| Net Income |
-28.48M |
| Free Cash Flow |
n/a |
| Net Cash |
-2.88B |
| Net Cash / Share |
-12.40 |
| Gross Margin |
49.52% |
| Operating Margin |
n/a |
| Profit Margin |
-3.60% |
| FCF Margin |
n/a |
| ROA |
6.04% |
| ROE |
10.31% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 |
|---|
| Revenue | 778 | 746 |
| Revenue Growth | 4.31% | - |
| Gross Profit | 395 | 357 |
| Operating Income | 184 | 80.85 |
| Net Income | -20.85 | -5.87 |
| Shares Outstanding | 232 | 232 |
| Earnings Per Share | -0.09 | -0.03 |
| Operating Cash Flow | 149 | 120 |
| Capital Expenditures | -57.26 | -72.61 |
| Free Cash Flow | 91.78 | 46.95 |
| Cash & Equivalents | 63.03 | 96.79 |
| Total Debt | 2,848 | 2,238 |
| Net Cash / Debt | -2,785 | -2,141 |
| Assets | 2,581 | 2,709 |
| Liabilities | 3,222 | 2,663 |
| Book Value | -643 | 44.36 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Sotera Health Company |
| Country |
United States |
| Employees |
2,900 |
| CEO |
Michael B. Petras |
Stock Information
| Ticker Symbol |
SHC |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Diagnostics & Research |
| Unique Identifier |
NASDAQ: SHC |
| IPO Date |
November 20, 2020 |
Description
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the United States and internationally. Its sterilization services include gamma and electron beam irradiation, and EO processing; and lab services comprise analytical chemistry, medical device, and pharmaceutical lab testing, as well as microbiology testing. The company also provides Co-60 and gamma irradiators, which are principal components to the gamma sterilization process. Its microbiology testing services help customers to identify and measure the potential risks of microbes to a product and ensure that the quality of the products is maintained; and advisory services help customers in navigating the regulatory requirements applicable throughout the product lifecycle. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is based in Broadview Heights, Ohio.